+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Advanced Drug Delivery Market (2023-2028) by Product, End User, Geography, Competitive Analysis, and Impact of Covid-19, Ansoff Analysis

  • PDF Icon

    Report

  • 188 Pages
  • February 2024
  • Region: Global
  • Infogence Global Research
  • ID: 5601617
The Global Advanced Drug Delivery Market is estimated to be USD 68.53 Bn in 2023 and is expected to reach USD 143.07 Bn by 2028 growing at a CAGR of 15.86%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the Global Advanced Drug Delivery Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

  • The Global Advanced Drug Delivery Market is segmented based on Product, End User, and Geography.
  • By Product, the market is classified into Drug Eluting Lens, Microneedle Patch, Hydrogel Drug Delivery, and Nano Carrier.
  • By End User, the market is classified into Hospitals, Specialized Clinics, and Others.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are 3M Company, Alnylam Pharmaceuticals, Altaris Capital Partners, Antares Pharma, B Braun Melsungen, Bausch Health Companies, Baxter International, Becton Dickinson and Company, Biogen, Eisai, Enable Injections, Endo International, Gerresheimer, Insulet, Johnson & Johnson Services, Koninklijke Philips, Micropoint Technologies, Novo Nordisk, Ocular Therapeutix, Smiths Medical, The Takeda Pharmaceutical Company, West Pharmaceutical Services, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Advanced Drug Delivery Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The publisher analyses the Global Advanced Drug Delivery Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Advanced Drug Delivery Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Rise in Prevalence of Chronic Disorders that Require the Use of Drug Delivery Systems
4.1.2 Surge in Healthcare Expenditure Globally
4.1.3 Technological Advancements
4.2 Restraints
4.2.1 Increasing Drug Recalls and Drug Failures
4.2.2 Government Regulations Delaying the Processes
4.2.3 Side Effects and Risk Associated with the Drugs
4.3 Opportunities
4.3.1 Rising Demand for Cost-Effective Healthcare Treatment
4.3.2 Growing Focus Towards Home Care and Self-Administration
4.4 Challenges
4.4.1 Increasing Cost of High End Products
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Advanced Drug Delivery Market, By Product
6.1 Introduction
6.2 Drug Eluting Lens
6.3 Microneedle Patch
6.4 Hydrogel Drug Delivery
6.5 Nano Carrier
7 Global Advanced Drug Delivery Market, By End User
7.1 Introduction
7.2 Hospitals
7.3 Specialized clinics
8 Americas’ Advanced Drug Delivery Market
8.1 Introduction
8.2 Argentina
8.3 Brazil
8.4 Canada
8.5 Chile
8.6 Colombia
8.7 Mexico
8.8 Peru
8.9 United States
8.10 Rest of Americas
9 Europe’s Advanced Drug Delivery Market
9.1 Introduction
9.2 Austria
9.3 Belgium
9.4 Denmark
9.5 Finland
9.6 France
9.7 Germany
9.8 Italy
9.9 Netherlands
9.10 Norway
9.11 Poland
9.12 Russia
9.13 Spain
9.14 Sweden
9.15 Switzerland
9.16 United Kingdom
9.17 Rest of Europe
10 Middle East and Africa’s Advanced Drug Delivery Market
10.1 Introduction
10.2 Egypt
10.3 Israel
10.4 Qatar
10.5 Saudi Arabia
10.6 South Africa
10.7 United Arab Emirates
10.8 Rest of MEA
11 APAC’s Advanced Drug Delivery Market
11.1 Introduction
11.2 Australia
11.3 Bangladesh
11.4 China
11.5 India
11.6 Indonesia
11.7 Japan
11.8 Malaysia
11.9 Philippines
11.10 Singapore
11.11 South Korea
11.12 Sri Lanka
11.13 Thailand
11.14 Taiwan
11.15 Rest of Asia-Pacific
12 Competitive Landscape
12.1 Competitive Quadrant
12.2 Market Share Analysis
12.3 Strategic Initiatives
12.3.1 M&A and Investments
12.3.2 Partnerships and Collaborations
12.3.3 Product Developments and Improvements
13 Company Profiles
13.1 3M Company
13.2 Alnylam Pharmaceuticals
13.3 Altaris Capital Partners
13.4 Antares Pharma
13.5 B Braun Melsungen
13.6 Bausch Health Companies
13.7 Baxter International
13.8 Becton Dickinson and Company
13.9 Biogen
13.10 Eisai
13.11 Enable Injections
13.12 Endo International
13.13 Gerresheimer
13.14 Insulet
13.15 Johnson & Johnson Services
13.16 Koninklijke Philips
13.17 Micropoint Technologies
13.18 Novo Nordisk
13.19 Ocular Therapeutix
13.20 Smiths Medical
13.21 The Takeda Pharmaceutical Company
13.22 West Pharmaceutical Services
14 Appendix
14.1 Questionnaire

Companies Mentioned

  • 3M Company
  • Alnylam Pharmaceuticals
  • Altaris Capital Partners
  • Antares Pharma
  • B Braun Melsungen
  • Bausch Health Companies
  • Baxter International
  • Becton Dickinson and Company
  • Biogen
  • Eisai
  • Enable Injections
  • Endo International
  • Gerresheimer
  • Insulet
  • Johnson & Johnson Services
  • Koninklijke Philips
  • Micropoint Technologies
  • Novo Nordisk
  • Ocular Therapeutix
  • Smiths Medical
  • The Takeda Pharmaceutical Company
  • West Pharmaceutical Services